Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.